APOBEC3B and cholangiocarcinoma: In contrast, the same SNP rs2267401 was associated with decreased risk of cholangiocarcinoma and lower APOBEC3B promoter activity in this tumor type, likely due to overexpression of the transcriptional repressor TFAP2A [43].